Request Trial

Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

UK-Switzerland strike trade deal with first-of-its-kind pharma rules
Regulation & Industry
UK-Switzerland strike trade deal with first-of-its-kind pharma rules
An enhanced agreement between the two countries cements existing protections for pharma innovators and is being hailed by the industry as a boost for investment and research.   14 July 2026
Interview: How BlueRock Therapeutics is layering IP in stem cell therapies
In-house counsel
Interview: How BlueRock Therapeutics is layering IP in stem cell therapies
The company’s VP of IP explains how he is protecting the process, staying ahead of outside counsel, and why a biosimilar path is only a matter of time.   13 July 2026
Explaining genetically engineered rodents to a jury—and ultimately beating Amgen
Biotech
Explaining genetically engineered rodents to a jury—and ultimately beating Amgen
Harbour’s trial counsel shares the strategy behind the company’s $20m win, revealing how a highly technical patent dispute became a case about credibility as much as science.   10 July 2026
Pharma
Exelixis opens two-front patent dispute over Cabometyx copies
Separate lawsuits target Indian and Taiwanese pharma companies as Exelixis seeks to keep rival cabozantinib products off the US market until key patents expire.   9 July 2026
Biotech
BioNTech and Pfizer secure big European win over mRNA patent
UPC judges revoke a patent asserted against the companies over their Comirnaty COVID-19 vaccine, in a ruling that clarified the court’s key principles on exclusive licences, novelty and inventive step.   8 July 2026
Careers
WilmerHale trade secrets expert moves to new firm
Focusing on technology and life sciences clients, the new San Fran-based Debevoise & Plimpton hire brings both in-house and private practice litigation experience across trade secrets and commercial disputes.   7 July 2026
MedTech
UPC revives patent, but timing sinks Guardant’s appeal
The Unified Patent Court delivers a mixed ruling in a dispute over liquid biopsy technology, overturning a finding that a patent was likely invalid while refusing to grant interim relief because of the patent owner’s delay.   6 July 2026
MedTech
China’s medtech shake-up forces rethink on pricing, IP and innovation
A report warns that procurement reforms in Mainland China, alongside the rise of open robotics platforms, supply chain disruption and GLP-1 drugs, are challenging existing medtech business models.   3 July 2026
Biotech
LSD trade secrets suit over clinical trail info thrown out by judge
A federal court has ruled in a dispute between a clinical trial technology company and a psychedelic drug developer over allegations of trade secret misuse during a bidding process.   2 July 2026
Careers
HGF expands European offering with pair of in-house hires
The firm has appointed two new partners in Basel and Bristol, adding decades of expertise from the pharmaceutical and biotech sectors to its growing life sciences practice.   2 July 2026

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.